Telomir Pharmaceuticals Inc (TELO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.160.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TELO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | |
|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||
| R&D Expenses | 3.0 | 2.4 | 2.2 | 1.6 | 0.8 | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | — | 4.3 | 1.6 | — | — |
| Interest & Investment Income | 0.2 | 0.1 | — | — | — | — |
| Net Income | ||||||
| Net Income | (5.9) | (10.4) | (16.5) | (13.1) | (0.9) | — |
| Per Share | ||||||
| Basic EPS | (0.10) | (0.33) | 0.56 | 0.48 | (0.03) | — |
| Diluted EPS | (0.10) | (0.33) | 0.56 | 0.48 | (0.03) | — |
| Basic Weighted Avg Shares | 60.8 | 31.7 | 29.5 | 27.3 | 26.8 | — |
| Diluted Weighted Avg Shares | 60.8 | 31.7 | 29.5 | 27.3 | 26.8 | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.